Pure Global

STA® - Control LA 1+2 - India CDSCO Medical Device Registration

STA® - Control LA 1+2 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001026_e3f7a76de8130774715080c02d1adb4e_976c5a138f24880068080f34d053f048. This device is marketed under the brand name Liatest AT III. The license holder is Syndicate Diagnostics Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
STA® - Control LA 1+2
UID: IMP/IVD/2020/001026_e3f7a76de8130774715080c02d1adb4e_976c5a138f24880068080f34d053f048

Brand Name

Liatest AT III

Device Class

Class C

Approving Authority

CDSCO

Product Information

The STA® - Control LA 1 + 2 kit provides a lupus anticoagulant (Liatest AT III) negative plasma and a LA positive plasma. These plasmas are intended for the quality control of the tests for LA detection carried out with the following tests: – STA® - Staclot® dRVV Screen (Liatest AT III) – STA® - Staclot® dRVV Confirm (Liatest AT III) – Staclot® LA (Liatest AT III)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing